Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
989.12
+4.04 (0.41%)
At close: Mar 16, 2026, 4:00 PM EDT
988.00
-1.12 (-0.11%)
After-hours: Mar 16, 2026, 7:35 PM EDT
Eli Lilly Employees
Eli Lilly and Company had 50,000 employees as of December 31, 2025. The number of employees increased by 3,000 or 6.38% compared to the previous year.
Employees
50,000
Change (1Y)
3,000
Growth (1Y)
6.38%
Revenue / Employee
$1,303,580
Profits / Employee
$412,800
Market Cap
883.64B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 50,000 | 3,000 | 6.38% |
| Dec 31, 2024 | 47,000 | 4,000 | 9.30% |
| Dec 31, 2023 | 43,000 | 4,000 | 10.26% |
| Dec 31, 2022 | 39,000 | 4,000 | 11.43% |
| Dec 31, 2021 | 35,000 | 0 | - |
| Dec 31, 2020 | 35,000 | 1,375 | 4.09% |
| Dec 31, 2019 | 33,625 | -5,055 | -13.07% |
| Dec 31, 2018 | 38,680 | -1,975 | -4.86% |
| Dec 31, 2017 | 40,655 | -1,320 | -3.14% |
| Dec 31, 2016 | 41,975 | 700 | 1.70% |
| Dec 31, 2015 | 41,275 | 2,140 | 5.47% |
| Dec 31, 2014 | 39,135 | 1,210 | 3.19% |
| Dec 31, 2013 | 37,925 | -425 | -1.11% |
| Dec 31, 2012 | 38,350 | 270 | 0.71% |
| Dec 31, 2011 | 38,080 | -270 | -0.70% |
| Dec 31, 2010 | 38,350 | -2,010 | -4.98% |
| Dec 31, 2009 | 40,360 | -140 | -0.35% |
| Dec 31, 2008 | 40,500 | -100 | -0.25% |
| Dec 31, 2007 | 40,600 | -900 | -2.17% |
| Dec 31, 2006 | 41,500 | -1,100 | -2.58% |
| Dec 31, 2005 | 42,600 | -1,900 | -4.27% |
| Dec 31, 2004 | 44,500 | -1,600 | -3.47% |
| Dec 31, 2003 | 46,100 | 2,400 | 5.49% |
| Dec 31, 2002 | 43,700 | 2,600 | 6.33% |
| Dec 31, 2001 | 41,100 | 5,400 | 15.13% |
| Dec 31, 2000 | 35,700 | 4,400 | 14.06% |
| Dec 31, 1999 | 31,300 | 1,500 | 5.03% |
| Dec 31, 1998 | 29,800 | -1,300 | -4.18% |
| Dec 31, 1997 | 31,100 | 1,900 | 6.51% |
| Dec 31, 1996 | 29,200 | 2,400 | 8.96% |
| Dec 31, 1995 | 26,800 | 1,900 | 7.63% |
| Dec 31, 1994 | 24,900 | -7,800 | -23.85% |
| Dec 31, 1993 | 32,700 | 500 | 1.55% |
| Dec 31, 1992 | 32,200 | 1,400 | 4.55% |
| Dec 31, 1991 | 30,800 | 1,300 | 4.41% |
| Dec 31, 1990 | 29,500 | 1,700 | 6.12% |
| Dec 31, 1989 | 27,800 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,200 |
| AstraZeneca | 95,100 |
| Novartis AG | 75,267 |
| Merck & Co. | 75,000 |
| Pfizer | 75,000 |
| Novo Nordisk | 69,505 |
| GSK plc | 66,841 |
| AbbVie | 57,000 |
LLY News
- 13 hours ago - Lilly's EBGLYSS (lebrikizumab-lbkz) is the first and only selective IL-13 inhibitor to deliver positive Phase 3 outcomes in patients aged six months to 18 years with moderate-to-severe atopic dermatitis - PRNewsWire
- 3 days ago - Invesco Rising Dividends Fund Q4 2025 Portfolio Activity - Seeking Alpha
- 4 days ago - Using Obesity Drug? Eli Lilly Flags Unknown Impurity Found In Compounded Weight Loss Drugs With Vitamin B12 - Benzinga
- 4 days ago - Eli Lilly: The Weight-Loss Craze Isn't Over - Seeking Alpha
- 4 days ago - Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline - Benzinga
- 4 days ago - Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks - Reuters
- 5 days ago - India warns drugmakers against direct or surrogate weight-loss drug and obesity ads - Reuters
- 5 days ago - Goldman Sachs Large Cap Equity Fund Q4 2025 Portfolio Activity - Seeking Alpha